TY  - GEN
AU  - Geyer,Mark B
AU  - Jacobson,Judith S
AU  - Freedman,Jason
AU  - George,Diane
AU  - Moore,Virginia
AU  - van de Ven,Carmella
AU  - Satwani,Prakash
AU  - Bhatia,Monica
AU  - Garvin,James H
AU  - Bradley,Mary Brigid
AU  - Harrison,Lauren
AU  - Morris,Erin
AU  - Della-Latta,Phyllis
AU  - Schwartz,Joseph
AU  - Baxter-Lowe,Lee A
AU  - Cairo,Mitchell S
TI  - A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients
SN  - 1365-2141
PY  - 2011///1128
KW  - Alemtuzumab
KW  - Antibiotic Prophylaxis
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antibodies, Neoplasm
KW  - Antilymphocyte Serum
KW  - Busulfan
KW  - Child
KW  - Child, Preschool
KW  - Cord Blood Stem Cell Transplantation
KW  - methods
KW  - Cyclophosphamide
KW  - Female
KW  - Genetic Diseases, Inborn
KW  - surgery
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - epidemiology
KW  - Granulocyte Colony-Stimulating Factor
KW  - therapeutic use
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - Humans
KW  - Leukocyte Count
KW  - Male
KW  - Melphalan
KW  - Myeloablative Agonists
KW  - Neoplasms
KW  - Neutrophils
KW  - Recombinant Proteins
KW  - Retrospective Studies
KW  - T-Lymphocytes
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - Whole-Body Irradiation
N1  - Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2141.2011.08822.x
ER  -